386 filings
Page 4 of 20
8-K
434gp1x
7 Nov 18
Melinta Therapeutics Reports Third Quarter 2018 Financial Results
8:27am
8-K
sys4xt0dsu8
5 Nov 18
Departure of Directors or Certain Officers
5:21pm
8-K
pvr4sgn p0ksuikhk
24 Oct 18
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
4:59pm
8-K
5ihxcqq
5 Oct 18
Departure of Directors or Certain Officers
5:18pm
8-K
rn87hm
2 Oct 18
Entry into a Material Definitive Agreement
4:55pm
8-K
8hta mdbrzqhzavm9nlf
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
mm14uxnlvq 2zz
19 Sep 18
Melinta Therapeutics Names Peter Milligan as Chief Financial Officer
9:23am
S-8
t54iuemsg 84wdz3e2n
4 Sep 18
Registration of securities for employees
12:00am
S-8
2jwhy
4 Sep 18
Registration of securities for employees
12:00am
8-K
iaqjrathxk61ztndqh65
7 Aug 18
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
9:15am
8-K
2ma30e7x
14 Jun 18
Departure of Directors or Certain Officers
12:00am
CT ORDER
3wbwbis
11 Jun 18
Confidential treatment order
12:00am
8-K/A
nbtodsch3n du0q
8 Jun 18
Financial Statements and Exhibits
4:39pm
8-K
q74rdrfdj lg
29 May 18
Melinta Therapeutics Announces Proposed Offering of Common Stock
5:18pm
424B5
c87by7j 8kju1q3torts
25 May 18
Prospectus supplement for primary offering
6:09am
FWP
fvcqidx
21 May 18
Free writing prospectus
4:13pm
424B5
a8s 55dtp4n6s
21 May 18
Prospectus supplement for primary offering
4:04pm